Roches OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
admin 19th July 2017 Uncategorised 0Roche
More: Roches OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
Source: MDlinx